Join the Population Council's Center for Biomedical Research Seminar Series presentation, “Assessing Demand for Novel Male Contraceptive Technologies,” presented by guest lecturer Steve Kretschmer on Tuesday, November 29 at 10am EST!
Steve Kretschmer is the founder and Executive Director of DesireLine, a consultancy firm designed to improve the health and wellbeing of the world’s most vulnerable populations through influencing and evolving the developmental sector via transformational impact. Over the past decade, Steve and his team have shaped the understanding and expectations for global demand of novel contraceptive technologies (CTs). Through envisioning, designing and leading the CT insights research, Steve and his team have created a benchmark for understanding global demand for novel male and female CTS.
The recent evidence on user demand for male contraceptive technologies (CTs) is very limited with a disproportionate focus on higher-income countries. Funded by The Bill & Melinda Gates Foundation, Steve and his team are implementing research intended to fill this gap and understand the size of opportunity for male CTs in low- and middle-income countries (LMICs) and the United States. This presentation will share results from the first 6 markets in which the research has been completed: Kenya, Nigeria, Cote d’Ivoire, Bangladesh, Vietnam, and the US. In the LMIC markets, research also included female partners of men interviewed. The results address the following questions about demand for male CTs:
Do men want additional Male CT options?
What additional Male CT options do men want?
Who wants which Male CT options?
Would women trust men to use Male CTs to protect them from pregnancy?
What will women do – continue using their own contraceptives or rely on their partner?
What will happen to condom use? (Implications for STI protection)